1. Maurizio Zangari is a hematologist and investigator at the Huntsman Cancer Institute (UT, USA). He is Professor of Medicine at the University of Utah (USA), Director of Experimental Therapeutics with the Blood and Marrow Transplant Program at the Huntsman Cancer Institute, and a member of the Imaging, Diagnostics and Therapeutics Program. He specializes in multiple myeloma and hypercoaguability (blood clotting) in cancer patients. He received a bachelors degree from the Enrico Fermi Institute of Padua ...
2. Tamara Berno is involved in clinical activity and experimental protocols of therapy in multiple myeloma patients (Phases I, II and III). She has worked as a postdoctoral fellow in the Myeloma Program at the University of Utah for the last 2 years.
3. The long-term objective of Fenghuang Zhan’s laboratory is to develop novel therapies to overcome drug resistance and deplete cancer stem cells in myeloma. The major focus of research in his laboratory is to define genes that make some myeloma cells resistant to chemotherapy and confirm their findings by in vitro (myeloma cell lines and primary myeloma cells) as well as in vivo (mouse models) studies.